Skip to main content
Equibles

MORGAN STANLEY

Position in IPHA — Innate Pharma SA

CIK 895421 NEW YORK, NY
Back to IPHA Full portfolio

Position in IPHA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$80,084
+$24,374 QoQ
Shares Held
43,524
0.0% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 10 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IPHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. IPHA ranks #360 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in IPHA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $80,084 43,524
2026-03-31 $55,710 43,524
2025-12-31 $81,189 46,394
2025-09-30 $103,378 53,564
2025-06-30 $92,971 51,224
2025-03-31 $77,472 43,524
2024-12-31 $80,084 43,524
2024-09-30 $99,669 43,524
2024-06-30 $84,436 43,524
2024-03-31 $127,077 44,124
2023-12-31 $129,791 46,354
2023-09-30 $113,733 44,954
2023-06-30 $144,675 47,049
2023-03-31 $138,857 48,722
2022-12-31 $184,138 49,367
2022-09-30 $113,704 56,852
2022-06-30 $125,814 46,598
2022-03-31 $151,045 44,954
2021-12-31 $179,344 39,330
2021-09-30 $109,387 17,729
2021-06-30 $120,512 36,630
2021-03-31 $241,834 56,110
2020-12-31 $20,981 5,130
2020-09-30 $6,032 1,571
2020-06-30 $85,220 12,441
2020-03-31 $22,044 3,300